Peptide Initiative

Dosing protocol · Healing & Recovery

Thymosin Beta-4 dosing & administration

The body's natural healing peptide that accelerates tissue repair and reduces inflammation

Suggested dose

2 – 5 mg

Once or twice weeklyFrequency
Subcutaneous injectionRoute
8-12 weeksCycle length

Dosing

How much Thymosin Beta-4 do I take?

Subcutaneous injection

Subcutaneous injection: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

  • 2-5 mg (community injectable practice for 'TB-500')

    Frequency
    Once or twice weekly
    Duration
    4-6 week loading phase, then weekly maintenance

    Documented community/research-practice injectable dosing for tissue repair; thymosin beta-4 has ~100% bioavailability by the subcutaneous route . Not an FDA-approved use.

Topical ophthalmic (eye drops)

Topical ophthalmic (eye drops): Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.

Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.

  • 0.1% (1 mg/mL) RGN-259 solution, 1 drop

    Frequency
    Several times daily (e.g. up to 5x/day)
    Duration
    4 weeks

    0.1% RGN-259 ophthalmic solution used in phase III neurotrophic keratopathy and dry-eye trials, applied as eye drops several times daily for ~4 weeks .

Intravenous injection

Intravenous injection: Delivered straight into a vein through a drip (IV), done by a clinician.

Bioavailability Complete (about 100%) — delivered straight into the bloodstream.

  • 450-1200 mg

    Frequency
    IV push daily for the first 3 days, then weekly
    Duration
    Total of 7 doses over ~5 weeks

    Doses studied in the RGN-352 acute myocardial infarction clinical program, given IV after PCI .

Timing

Best time to take

Morning or evening (flexible)

With food?

Not affected by food intake

If stacking

Best administered on different days than other injectable peptides to minimize injection site stress

Adjusting your dose

Increase if

  • Healing is slower than expected after 3-4 weeks
  • Inflammation remains high despite initial treatment
  • Underlying injury is more severe than initially assessed

Decrease if

  • Injection site reactions become bothersome
  • Excessive bruising or swelling develops
  • Systemic sensitivity symptoms appear

Signs of right dose

  • Visible improvement in wound appearance by week 2-3
  • Reduced pain and inflammation
  • Improved range of motion around injured area
  • Faster scar maturation

Administration

How do I use Thymosin Beta-4?

Reconstitution

What you need

  • Bacteriostatic water or normal saline
  • Sterile syringe (3-5 mL recommended)
  • Sterile needle (25-27 gauge)
  • Alcohol swabs
  • Vial of Thymosin Beta-4 powder

Injection

Route

Subcutaneous

Best sites

  • Lower abdomen (spare 2 inches around navel)
  • Outer thigh
  • Upper arm (back of triceps)
  • Rotate sites with each injection

Storage

Before reconstitution

Keep in original vial at 2-8°C. Protect from light and freezing. Stable for 36+ months when properly stored

After reconstitution

Store at 2-8°C in refrigerator. Do not freeze reconstituted solution

Signs of degradation — discard the vial

  • Cloudiness or particles in solution
  • Discoloration (should be clear to slightly yellow)
  • Unusual odor
  • Solution has been at room temperature for >4 hours

Sample daily schedule

  • Monday morning

    2-5 mg injection

    Site: Lower abdomen or outer thigh

    First dose of the week (loading phase)

  • Thursday morning

    2-5 mg injection

    Site: Opposite thigh or upper arm

    Second dose of the week (loading phase, then transition to maintenance)

  • Weekly (maintenance)

    2 mg injection

    Site: Rotate between abdomen, thighs, and arms

    After 4-6 week loading phase, reduce to once weekly for maintenance

Safety

Is Thymosin Beta-4 safe?

Side effects

Commonly reported: Injection site redness, Injection site swelling

Less common: Temporary mild headache, Mild bruising at injection site, Transient fatigue

Serious side effects

  • Allergic reaction

Stop and seek help if

  • Severe allergic reaction or anaphylaxis
  • Persistent injection site infection
  • Significant systemic adverse effects
  • Pregnancy is confirmed
  • No improvement in healing after 12 weeks (reassess approach)
  • Active systemic infection develops without antibiotic coverage

This is general educational information. Always consult with a healthcare provider before starting, stopping, or modifying any peptide therapy. Do not self-diagnose or treat serious medical conditions.

Interaction notes · no rating stored

  • BPC-157: Synergistic tissue repair effects, stagger injection days
  • Ipamorelin: Complementary growth hormone support, safe to combine
  • Sermorelin: Additive growth hormone effects, monitor for excessive stimulation
  • Collagen peptides: Support structural repair, no pharmacological interaction
  • Antibiotics: No significant interaction, appropriate for infected wounds
  • NSAIDs: May slightly reduce inflammation amplification, consider timing
  • Corticosteroids: May reduce inflammatory signaling, balance anti-inflammatory effects
  • Anticoagulants: Monitor injection sites for excessive bruising, no systemic interaction
  • Vitamin C: Enhances collagen synthesis for better wound healing
  • Zinc: Supports immune function during tissue repair
  • Protein/amino acids: Provide building blocks for healing, complementary
  • Probiotics: Support immune function without interaction
  • Avoid: High-dose immunosuppressive supplements without medical approval

Published research

What the studies show

  • Moderate human trials (Phase 1-2)
  • Research compound
  1. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

    Goldstein AL, Hannappel E, Sosne G, et al. · 2012PubMed

    This study investigated the properties and effects of Thymosin Beta-4, contributing to our understanding of its mechanism of action and potential therapeutic applications.

  2. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide

    Philp D, Kleinman HK · 2010PubMed

    This study investigated the properties and effects of Thymosin Beta-4, contributing to our understanding of its mechanism of action and potential therapeutic applications.

  3. Thymosin beta4 and cardiac repair

    Shrivastava S, Srivastava D, Olson EN, et al. · 2010PubMed

    This study investigated the properties and effects of Thymosin Beta-4, contributing to our understanding of its mechanism of action and potential therapeutic applications.

  4. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock

    Badamchian M, Fagarasan MO, Danner RL, et al. · 2003PubMed

    This study investigated the properties and effects of Thymosin Beta-4, contributing to our understanding of its mechanism of action and potential therapeutic applications.

  5. 0.1% RGN-259 (Thymosin beta-4) Ophthalmic Solution Promotes Healing in Neurotrophic Keratopathy: a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial

    Sosne G, Ousler GW, et al. · 2022NCBI

  6. A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 (RGN-352) for Treating Acute Myocardial Infarction

    RegeneRx Biopharmaceuticals (NCT01311518) · 2011ClinicalTrials.gov

Head to head

Thymosin Beta-4 compared

Studied for

Conditions Thymosin Beta-4 has been researched in

Want the full picture?

The complete Thymosin Beta-4 research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.